North America RNAi Technology Research
8 comprehensive market analysis studies and research reports on the North America RNAi Technology sector, offering an overview with historical data since 2019 and forecasts up to 2030. This includes a detailed market research of 108 companies, enriched with industry statistics, insights, and a lot more.

Healthcare
Categories
8 Healthcare Reports
Categories
Filters and Sort
Showing 8 of 8 results in RNAi Technology
Global Transcriptomics Market
CAGR: 5.05%
Study Period: 2020 - 2031
Region Covered: North America
Major Players:Roche, Thermo Fisher Scientific, Merck, GE Healthcare, Bio-Rad Laboratories
MicroRNA Market
CAGR: 15.05%
Study Period: 2020 - 2031
Region Covered: North America
Major Players:QIAGEN , Thermo Fisher Scientific, PerkinElmer, Illumina, Takara Bio
Antisense And RNAi Therapeutics Market
CAGR: 18.22%
Study Period: 2020 - 2031
Region Covered: North America
Major Players:Alnylam Pharmaceuticals, Biogen, Ionis Pharmaceuticals, Sarepta Therapeutics, Novartis
RNAi Technology Market
CAGR: 16.01%
Study Period: 2020 - 2031
Region Covered: North America
Major Players:Alnylam Pharmaceuticals, Silence Therapeutics, Arrowhead Pharmaceuticals, Thermo Fisher Scientific, Dicerna Pharmaceutic
MRNA Synthesis Service Market
CAGR: 7.60%
Study Period: 2019 - 2030
Region Covered: North America
Major Players:Thermo Fisher Scientific, Lonza Group, TriLink BioTechnologies, Danaher, Catalent
RNA Therapeutics Market
CAGR: 9.20%
Study Period: 2019 - 2030
Region Covered: North America
Major Players:Moderna, BioNTech, Alnylam Pharmaceuticals, Ionis Pharmaceuticals, Sarepta Therapeutics
Cell-Free RNA (cfRNA) Analysis Market
CAGR: 14.82%
Study Period: 2020 - 2030
Region Covered: North America
Major Players:Norgen Biotek Corp, QIAGEN , Zymo Research, Promega, Bio-Rad Laboratories
RNA Analysis Market
CAGR: 13.6%
Study Period: 2019 - 2030
Region Covered: North America
Major Players:Thermo Fisher Scientific, Roche, Agilent Technologies, Bio-Rad Laboratories, Merck
Yay! You have seen it all
CONTACT US
When decisions matter, industry leaders turn to our analysts. Let’s talk.







